Epidemiology, Pathogenicity and Emerging Resistances in Staphylococcus pasteuri: From Mammals and Lampreys, to Man

Author(s): Vincenzo Savini, Chiara Catavitello, Azaira Bianco, Andrea Balbinot, Domenico D'Antonio.

Journal Name: Recent Patents on Anti-Infective Drug Discovery

Volume 4 , Issue 2 , 2009

Become EABM
Become Reviewer


Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed.

Keywords: Staphylococcus pasteuri, methicillin, oxacillin, macrolide, lincosamide, streptogramin, tetracyclines, chloramphenicol, fosfomycin

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [123 - 129]
Pages: 7
DOI: 10.2174/157489109788490352
Price: $58

Article Metrics

PDF: 13